COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening
New Delhi: Bharat Biotech's intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday.The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening, they said.The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries.Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged them to wear masks in crowded places, while also directing officials to strengthen surveillance measures, especially at international airports.Read all the Latest News, Trending News, Cricket News, Bollywood News,India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
Air India to cut Delhi-Toronto flight time by 3 hours, resume non-stop services from August 1
J&K cop on Amarnath Yatra duty shot dead in Anantnag terror attack; TRF claims responsibility
Jaishankar meets Canada's Anita Anand, discusses bilateral cooperation and shared interests
Delhi, Bengaluru, Hyderabad... Neet paper leak protest spreads nationwide even as govt reaches out to CJP, Opposition
Why is India seeing 95% cloud cover despite a Super El Niño?